LONDON and NEW YORK, Jan. 08, 2024 (GLOBE NEWSWIRE) -- OKYO Pharma Limited (OKYO), a clinical-stage biopharmaceutical company developing innovative therapies for the treatment of inflammatory dry eye ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results